7Baggers

Establishment Labs Quarterly Balance Sheets Chart

Quarterly
 | 
Annual
 
 Goodwill  
 Account Receivables  
 Cash and Cash Eq  
 Account Payables  
 Inventory  
20200630 20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20240331 20240630 20240930 20241231 20250331 20250630 013.5327.0540.5854.167.6381.1694.68Milllion

Establishment Labs Quarterly Balance Sheets Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-09-30 2019-06-30 2019-03-31 2018-09-30 2018-06-30 
                            
  assets                          
  current assets:                          
  cash and cash equivalents54,639,000 69,178,000 90,347,000                        
  accounts receivable70,092,000 63,236,000 65,002,000 67,251,000 59,982,000 50,838,000 54,693,000 51,395,000 41,049,000 35,423,000 31,246,000 32,003,000 29,689,000 24,437,000 24,704,000 23,093,000 23,777,000 19,127,000 18,756,000 17,142,000 21,615,000 22,022,000 21,312,000 20,115,000 18,248,000 16,204,000 
  inventory94,683,000 90,425,000 78,766,000 67,122,000 64,213,000 72,489,000 67,935,000 56,370,000 46,141,000 36,583,000 31,557,000 26,532,000 28,538,000 28,407,000 26,652,000 23,946,000 22,377,000 23,210,000 28,400,000 29,057,000 25,512,000 26,387,000 26,540,000 23,752,000 15,365,000 13,223,000 
  prepaid expenses and other current assets9,754,000 8,857,000 8,922,000 8,883,000 7,337,000 7,388,000 11,903,000 11,070,000 12,004,000 11,543,000 10,013,000 6,634,000 7,133,000 7,012,000 8,726,000 4,336,000 4,194,000 5,439,000 5,431,000 3,841,000 7,173,000 6,968,000 4,455,000 4,714,000 5,597,000 4,273,000 
  total current assets229,168,000 231,696,000 243,037,000 182,953,000 186,132,000 203,695,000 186,721,000 209,017,000 142,041,000 149,904,000 138,165,000 156,428,000 110,016,000 113,271,000 124,705,000 128,181,000 128,298,000 132,299,000 134,018,000 136,422,000 147,896,000 97,936,000 84,177,000 91,716,000 104,787,000 45,342,000 
  long-term assets:                          
  property and equipment, net of accumulated depreciation76,362,000 76,390,000 78,028,000 79,423,000 79,546,000 79,244,000 72,642,000 66,208,000 57,051,000 51,092,000 39,214,000 35,359,000 23,301,000 18,658,000 16,781,000 16,590,000 16,321,000 16,202,000 16,263,000 16,085,000 16,235,000 16,650,000 16,708,000    
  goodwill1,209,000 1,209,000 1,209,000 465,000 465,000 465,000 465,000 465,000 465,000 465,000 465,000 465,000 465,000 465,000 465,000 465,000 465,000 465,000 465,000 465,000 465,000 465,000 465,000 465,000 465,000 465,000 
  intangible assets, net of accumulated amortization11,186,000 11,566,000 11,683,000 9,783,000 10,041,000 9,515,000 5,705,000 4,229,000 4,367,000 4,608,000 4,632,000 4,414,000 4,470,000 4,371,000 3,654,000 3,859,000 4,126,000 4,148,000 3,537,000 3,480,000 3,465,000 2,893,000 3,081,000    
  right-of-use operating lease assets4,802,000 5,192,000 5,561,000 4,849,000 3,717,000 3,908,000 3,561,000 3,811,000 3,998,000 3,702,000 3,730,000 2,023,000 2,113,000 2,206,000 2,307,000 2,408,000 2,511,000 2,610,000         
  other non-current assets6,941,000 7,311,000 7,313,000 5,212,000 5,187,000 5,011,000 1,439,000 1,569,000 1,437,000 1,290,000 1,447,000 1,194,000 1,191,000 558,000 447,000 617,000 628,000 664,000 401,000 360,000 362,000 312,000 370,000 325,000 283,000 1,071,000 
  total assets329,668,000 333,364,000 346,831,000 282,685,000 285,088,000 301,838,000 270,533,000 285,299,000 209,359,000 211,061,000 187,653,000 199,883,000 141,556,000 139,529,000 148,359,000 152,120,000 152,349,000 156,388,000 154,684,000 156,812,000 168,423,000 118,256,000 104,801,000 108,956,000 121,472,000 63,323,000 
  liabilities and shareholders’ equity                          
  current liabilities:                          
  accounts payable55,806,000 45,188,000 44,760,000 34,397,000 28,420,000 31,070,000 28,928,000 24,359,000 20,254,000 20,034,000 14,878,000 15,986,000 16,651,000 14,475,000 10,257,000 10,020,000 8,994,000 9,722,000 6,954,000 8,293,000 9,881,000 9,383,000 8,531,000 5,583,000 5,492,000 7,471,000 
  accrued liabilities17,367,000 20,604,000 16,536,000 13,821,000 11,812,000 15,207,000 19,388,000 17,434,000 19,638,000 17,237,000 16,705,000 17,600,000 18,057,000 16,236,000 19,178,000 16,180,000 14,408,000 14,532,000 12,092,000 10,517,000 10,555,000 9,866,000 8,718,000 6,846,000 5,861,000 4,900,000 
  other liabilities, short-term7,569,000 3,246,000 6,982,000 2,280,000 1,660,000 1,739,000 1,986,000 1,480,000 1,579,000 1,688,000 793,000 1,166,000 1,802,000 1,178,000 1,015,000 1,070,000 1,431,000 1,646,000         
  total current liabilities80,742,000 69,038,000 68,278,000 50,498,000 41,892,000 48,016,000 50,302,000 43,273,000 41,471,000 38,959,000 32,376,000 34,752,000 36,510,000 31,889,000 30,450,000 27,270,000 24,833,000 25,900,000 20,141,000 20,552,000 22,460,000 20,346,000 21,386,000 16,558,000 14,851,000 18,772,000 
  long-term liabilities:                          
  note payable, net of debt discount and issuance costs221,133,000 220,340,000  194,360,000 193,732,000 192,186,000 185,321,000 181,970,000 178,648,000                  
  operating lease liabilities, non-current3,364,000 3,803,000 4,203,000 3,825,000 2,989,000 3,180,000 2,918,000 3,191,000 3,415,000 3,200,000 3,323,000 1,726,000 1,805,000 1,900,000 1,967,000 2,041,000 1,630,000 1,923,000         
  other liabilities, long-term1,666,000 1,633,000 1,678,000 1,292,000 1,456,000 1,545,000 1,505,000 1,992,000 1,821,000 1,626,000 2,243,000 2,056,000 1,821,000 2,392,000 2,145,000 2,219,000 1,820,000 2,332,000         
  total liabilities306,905,000 294,814,000 293,736,000 249,975,000 240,069,000 244,927,000 240,046,000 230,426,000 225,355,000 219,246,000 186,134,000 184,016,000 93,721,000 88,790,000 86,799,000 83,291,000 79,798,000 81,427,000 74,727,000 75,026,000 78,116,000 74,452,000 51,014,000 47,926,000 44,485,000 60,952,000 
  commitments and contingencies                          
  shareholders’ equity:                          
  common shares — zero par value, unlimited amount authorized; 29,377,603 and 29,195,439 shares issued at june 30, 2025 and december 31, 2024, respectively; 28,969,533 and 28,787,369 shares outstanding at june 30, 2025 and december 31, 2024, respectively425,855,000                          
  additional paid-in-capital82,130,000 79,117,000 76,992,000 73,569,000 70,004,000 66,841,000 60,335,000 56,473,000 53,171,000 49,911,000 46,659,000 43,761,000 40,018,000 36,584,000 33,856,000 30,947,000 28,427,000 26,717,000 25,658,000 24,338,000 22,799,000 19,998,000 18,640,000 16,837,000 12,891,000 30,354,000 
  treasury shares, at cost, 408,070 shares held at june 30, 2025 and december 31, 2024-2,854,000                          
  accumulated deficit-481,995,000 -465,402,000 -444,692,000 -410,161,000 -393,479,000 -376,298,000 -339,554,000 -310,281,000 -293,536,000 -281,594,000 -268,032,000 -249,424,000 -212,318,000 -206,385,000 -192,194,000 -177,516,000 -172,194,000 -165,246,000 -159,602,000 -155,355,000 -144,884,000 -121,569,000 -108,794,000 -99,754,000 -78,461,000 -79,767,000 
  accumulated other comprehensive income-373,000 3,157,000 3,285,000 3,226,000 3,116,000 2,084,000 1,954,000 1,810,000 2,313,000 2,715,000 2,603,000 2,534,000 1,550,000 3,657,000 3,536,000 2,256,000 3,814,000 2,873,000 4,003,000 3,725,000 3,512,000 1,021,000 362,000 516,000 799,000 599,000 
  total shareholders’ equity22,763,000 38,550,000 53,095,000 32,710,000 45,019,000 56,911,000 30,487,000 54,873,000 -15,996,000  1,519,000 15,867,000 47,835,000 50,739,000 61,560,000 68,829,000 72,551,000 74,961,000 79,957,000 81,786,000 90,307,000 43,804,000 53,787,000 61,030,000 76,987,000 2,371,000 
  total liabilities and shareholders’ equity329,668,000 333,364,000 346,831,000 282,685,000 285,088,000 301,838,000 270,533,000 285,299,000 209,359,000 211,061,000 187,653,000 199,883,000 141,556,000 139,529,000 148,359,000 152,120,000 152,349,000 156,388,000 154,684,000 156,812,000 168,423,000 118,256,000 104,801,000 108,956,000 121,472,000 63,323,000 
  common shares — zero par value, unlimited amount authorized; 29,316,407 and 29,195,439 shares issued at march 31, 2025 and december 31, 2024, respectively; 28,908,337 and 28,787,369 shares outstanding at march 31, 2025 and december 31, 2024, respectively 424,532,000                         
  treasury shares, at cost, 408,070 shares held at march 31, 2025 and december 31, 2024 -2,854,000                         
  note payable, oaktree, net of debt discount and issuance costs  219,577,000       175,461,000 148,192,000 145,482,000               
  common shares – zero par value, unlimited amount of shares authorized at december 31, 2024 and 2023; 29,195,439 and 26,495,250 shares issued at december 31, 2024 and 2023, respectively; 28,787,369 and 26,087,180 shares outstanding at december 31, 2024 and 2023, respectively  420,364,000                        
  treasury shares, at cost, 408,070 shares held at december 31, 2024 and 2023  -2,854,000                        
  cash   39,697,000 54,600,000 72,980,000 52,190,000 90,182,000 42,847,000 66,355,000 65,349,000 91,259,000 44,656,000 53,415,000 64,623,000 76,806,000 77,950,000 84,523,000 81,431,000 86,382,000 93,596,000 42,559,000 31,870,000 43,135,000 65,577,000 11,642,000 
  common shares — zero par value, unlimited amount authorized; 28,372,099 and 26,495,250 shares issued at september 30, 2024 and december 31, 2023, respectively; 27,964,029 and 26,087,180 shares outstanding at september 30, 2024 and december 31, 2023, respectively   368,930,000                       
  treasury shares, at cost, 408,070 shares held at september 30, 2024 and december 31, 2023   -2,854,000                       
  common shares — zero par value, unlimited amount authorized; 28,349,936 and 26,495,250 shares issued at june 30, 2024 and december 31, 2023, respectively; 27,941,866 and 26,087,180 shares outstanding at june 30, 2024 and december 31, 2023, respectively    368,232,000                      
  treasury shares, at cost, 408,070 shares held at june 30, 2024 and december 31, 2023    -2,854,000                      
  common shares — zero par value, unlimited amount authorized; 27,884,749 and 26,495,250 shares issued at march 31, 2024 and december 31, 2023, respectively; 27,476,679 and 26,087,180 shares outstanding at march 31, 2024 and december 31, 2023, respectively     367,138,000                     
  treasury shares, at cost, 408,070 shares held at march 31, 2024 and december 31, 2023     -2,854,000                     
  shareholders’ equity                          
  common shares - zero par value, unlimited amount authorized; 26,213,504 and 24,815,908 shares issued at september 30, 2023 and december 31, 2022, respectively; 25,805,434 and 24,407,838 shares outstanding at september 30, 2023 and december 31, 2022, respectively      310,606,000                    
  treasury shares, at cost, 408,070 shares held at september 30, 2023 and december 31, 2022      -2,854,000                    
  common shares - zero par value, unlimited amount authorized; 26,181,033 and 24,815,908 shares issued at june 30, 2023 and december 31, 2022, respectively; 25,772,963 and 24,407,838 shares outstanding at june 30, 2023 and december 31, 2022, respectively       309,725,000                   
  treasury shares, at cost, 408,070 shares held at june 30, 2023 and december 31, 2022       -2,854,000                   
  common shares - zero par value, unlimited amount authorized; 24,869,763 and 24,815,908 shares issued at march 31, 2023 and december 31, 2022, respectively; 24,461,693 and 24,407,838 shares outstanding at march 31, 2023 and december 31, 2022, respectively        224,910,000                  
  treasury shares, at cost, 408,070 shares held at march 31, 2023 and december 31, 2022        -2,854,000                  
  note payable, madryn, net of debt discount and issuance costs            52,486,000 51,906,000 51,343,000 50,810,000 50,305,000 49,832,000 49,374,000 48,939,000 48,529,000 47,770,000 24,053,000 23,190,000   
  madryn put option            1,099,000 703,000 894,000 951,000 1,210,000 1,440,000 2,630,000 3,509,000 5,001,000 3,281,000 2,160,000 4,800,000   
  shareholders’ (deficit) equity:                          
  common shares - zero par value, unlimited amount of shares authorized at december 31, 2022 and 2021; 24,815,908 and 24,488,335 shares issued at december 31, 2022 and 2021, respectively; 24,407,838 and 24,080,265 shares outstanding at december 31, 2022 and 2021, respectively         223,637,000                 
  treasury shares, at cost, 408,070 shares held at december 31, 2022 and 2021         -2,854,000                 
  total shareholders’ (deficit) equity         -8,185,000                 
  common shares - zero par value, unlimited amount authorized; 24,750,397 and 24,488,335 shares issued at september 30, 2022 and december 31, 2021, respectively; 24,342,327 and 24,080,265 shares outstanding at september 30, 2022 and december 31, 2021, respectively          223,143,000                
  treasury shares, at cost, 408,070 shares held at september 30, 2022 and december 31, 2021          -2,854,000                
  common shares - zero par value, unlimited amount authorized; 24,638,037 and 24,488,335 shares issued at june 30, 2022 and december 31, 2021, respectively; 24,229,967 and 24,080,265 shares outstanding at june 30, 2022 and december 31, 2021, respectively           221,850,000               
  treasury shares, at cost, 408,070 shares held at june 30, 2022 and december 31, 2021           -2,854,000               
  common shares - zero par value, unlimited amount authorized; 24,602,156 and 24,488,335 shares issued at march 31, 2022 and december 31, 2021, respectively; 24,194,086 and 24,080,265 shares outstanding at march 31, 2022 and december 31, 2021, respectively            221,439,000              
  treasury shares, at cost, 408,070 shares held at march 31, 2022 and december 31, 2021            -2,854,000              
  common shares - zero par value, unlimited amount of shares authorized at december 31, 2021 and 2020; 24,488,335 and 23,925,789 shares issued at december 31, 2021 and 2020, respectively; 24,080,265 and 23,517,719 shares outstanding at december 31, 2021 and 2020, respectively             219,737,000             
  treasury shares, at cost, 408,070 shares held at december 31, 2021 and 2020             -2,854,000             
  common shares - zero par value, unlimited amount authorized; 24,394,766 and 23,925,789 shares issued at september 30, 2021 and december 31, 2020, respectively; 23,986,696 and 23,517,719 shares outstanding at september 30, 2021 and december 31, 2020, respectively              219,216,000            
  treasury shares, at cost, 408,070 shares held at september 30, 2021 and december 31, 2020              -2,854,000            
  common shares - zero par value, unlimited amount authorized; 24,133,453 and 23,925,789 shares issued at june 30, 2021 and december 31, 2020, respectively; 23,725,383 and 23,517,719 shares outstanding at june 30, 2021 and december 31, 2020, respectively               215,996,000           
  treasury shares, at cost, 408,070 shares held at june 30, 2021 and december 31, 2020               -2,854,000           
  common shares - zero par value, unlimited amount authorized; 24,094,051 and 23,925,789 shares issued at march 31, 2021 and december 31, 2020, respectively; 23,685,981 and 23,517,719 shares outstanding at march 31, 2021 and december 31, 2020, respectively                215,358,000          
  treasury shares, at cost, 408,070 shares held at march 31, 2021 and december 31, 2020                -2,854,000          
  common shares - zero par value, unlimited amount of shares authorized at december 31, 2020 and 2019; 23,925,789 and 21,057,040 shares issued at december 31, 2020 and 2019, respectively; 23,517,719 and 20,648,970 shares outstanding at december 31, 2020 and 2019, respectively                 213,471,000         
  treasury shares, at cost, 408,070 shares held at december 31, 2020 and 2019                 -2,854,000         
  other liabilities, short term                  1,095,000 1,742,000 2,024,000 1,097,000 4,137,000 4,129,000 3,498,000 1,333,000 
  other liabilities, long term                  2,582,000 2,026,000 2,126,000 3,055,000 3,415,000 3,378,000 3,431,000 5,361,000 
  common shares - zero par value, unlimited amount authorized; 23,827,680 and 21,057,040 shares issued at september 30, 2020 and december 31, 2019, respectively; 23,419,610 and 20,648,970 shares outstanding at september 30, 2020 and december 31, 2019, respectively                  212,752,000        
  treasury shares, at cost, 408,070 shares held at september 30, 2020 and december 31, 2019                  -2,854,000        
  common shares - zero par value, unlimited amount authorized; 23,762,787 and 21,057,040 shares issued at june 30, 2020 and december 31, 2019, respectively; 23,354,717 and 20,648,970 shares outstanding at june 30, 2020 and december 31, 2019, respectively                   211,932,000       
  treasury shares, at cost, 408,070 shares held at june 30, 2020 and december 31, 2019                   -2,854,000       
  common shares - zero par value, unlimited amount authorized; 23,735,013 and 21,057,040 shares issued at march 31, 2020 and december 31, 2019, respectively; 23,326,943 and 20,648,970 shares outstanding at march 31, 2020 and december 31, 2019, respectively                    211,734,000      
  treasury shares, at cost, 408,070 shares held at march 31, 2020 and december 31, 2019                    -2,854,000      
  common shares - zero par value, unlimited amount authorized; 20,983,139 and 20,672,025 shares issued at september 30, 2019 and december 31, 2018, respectively; 20,575,069 and 20,263,955 shares outstanding at september 30, 2019 and december 31, 2018, respectively                     147,208,000     
  treasury shares, at cost, 408,070 shares held at september 30, 2019 and december 31, 2018                     -2,854,000     
  common shares - zero par value, unlimited amount authorized; 20,882,419 and 20,672,025 shares issued at june 30, 2019 and december 31, 2018, respectively; 20,474,349 and 20,263,955 shares outstanding at june 30, 2019 and december 31, 2018, respectively                      146,433,000    
  treasury shares, at cost, 408,070 shares held at june 30, 2019 and december 31, 2018                      -2,854,000    
  property and equipment, net of accumulated depreciation of 5,653 and 5,230                       13,202,000   
  intangible assets, net of accumulated amortization of 1,410 and 1,213                       3,248,000   
  common shares - zero par value, unlimited amount authorized; 20,803,803 and 20,672,025 shares issued at march 31, 2019 and december 31, 2018, respectively; 20,395,733 and 20,263,955 shares outstanding at march 31, 2019 and december 31, 2018, respectively                       146,285,000   
  treasury shares, at cost, 408,070 shares held at march 31, 2019 and december 31, 2018                       -2,854,000   
  property and equipment, net of accumulated depreciation of 4,637 and 3,179                        12,892,000  
  intangible assets, net of accumulated amortization of 1,038 and 573                        2,970,000  
  restricted cash                        75,000 75,000 
  notes payable related party, including accrued interest                         5,068,000 
  madryn call option                          
  ordinary shares - 1.00 par value (class a and b), zero and 21,206,630 shares authorized at september 30, 2018 and december 31, 2017, respectively; zero and 13,427,536 shares issued at september 30, 2018 and december 31, 2017, respectively; zero and 12,206,326 shares outstanding at september 30, 2018 and december 31, 2017, respectively                          
  ordinary shares - no par value (class c, d, e, f, g and g-1), zero and 2,316,169 shares authorized at september 30, 2018 and december 31, 2017, respectively; zero and 2,316,169 shares issued and outstanding at september 30, 2018 and december 31, 2017, respectively                          
  common shares - zero par value, unlimited amount and 84,050,000 shares authorized at september 30, 2018 and december 31, 2017, respectively; 20,539,095 and zero shares issued at september 30, 2018 and december 31, 2017, respectively; 20,131,025 and zero shares outstanding at september 30, 2018 and december 31, 2017, respectively                        144,612,000  
  treasury shares, at cost, 408,070 and 1,221,210 shares held at september 30, 2018 and december 31, 2017, respectively                        -2,854,000  
  property and equipment, net of accumulated depreciation of 4,219 and 3,179                         13,241,000 
  intangible assets, net of accumulated amortization of 880 and 573                         3,129,000 
  ordinary shares - 1.00 par value (class a and b), 21,206,630 shares authorized at june 30, 2018 and december 31, 2017; 13,631,041 and 13,427,536 shares issued at june 30, 2018 and december 31, 2017, respectively; 12,409,831 and 12,206,326 shares outstanding at june 30, 2018 and december 31, 2017, respectively                         13,631,000 
  ordinary shares - no par value (class c, d, e, f, g and g-1), 4,191,169 and 2,316,169 shares authorized at june 30, 2018 and december 31, 2017, respectively; 3,327,343 and 2,316,169 shares issued and outstanding at june 30, 2018 and december 31, 2017, respectively                         44,019,000 
  common shares - 1.00 par value, 84,050,000 shares authorized at june 30, 2018 and december 31, 2017; zero shares issued and outstanding at june 30, 2018 and december 31, 2017                          
  treasury shares, at cost, 1,221,210 shares held at june 30, 2018 and december 31, 2017                         -6,465,000 

We provide you with 20 years of balance sheets for Establishment Labs stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Establishment Labs. Explore the full financial landscape of Establishment Labs stock with our expertly curated balance sheets.

The information provided in this report about Establishment Labs stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.